Ademola Adesola Ogunruku, APN | |
1 Clara Maass Dr, Belleville, NJ 07109-3550 | |
(973) 450-2111 | |
Not Available |
Full Name | Ademola Adesola Ogunruku |
---|---|
Gender | Male |
Speciality | |
Experience | Years |
Location | 1 Clara Maass Dr, Belleville, New Jersey |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1598376501 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
163WP0807X | Registered Nurse - Psychiatric/mental Health, Child & Adolescent | 26NJ01045500 (New Jersey) | Primary |
Mailing Address | Practice Location Address |
---|---|
Ademola Adesola Ogunruku, APN 1 Clara Maass Dr, Belleville, NJ 07109-3550 Ph: (973) 450-2111 | Ademola Adesola Ogunruku, APN 1 Clara Maass Dr, Belleville, NJ 07109-3550 Ph: (973) 450-2111 |
News Archive
Central Logic, the healthcare industry's leading provider of innovative patient flow software and consultative expertise, today announced it is expanding its flagship industry summit from a single annual gathering held each summer in its hometown of Salt Lake City to a semi-annual pair of conferences staged each spring and fall closer to both coasts.
T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive type of leukemia in which too many T-cell lymphoblasts, or immature white blood cells, are found in the bone marrow and blood.
Soligenix, Inc., a clinical stage biopharmaceutical company focused on developing products to treat serious inflammatory diseases where there remains an unmet medical need, as well as developing several biodefense vaccines and therapeutics, announced today promising preliminary results from a preclinical study with its ricin toxin vaccine RiVax™, in a non-human primate (NHP) lethal aerosol exposure model.
Bundled payments may be the "wave of the future," the Wall Street Journal suggests. Meanwhile, health care providers are working to get patients more involved in decisions about their care.
Scientists have used a genetically engineered vaccine to successfully eradicate high-grade precancerous cervical lesions in nearly one-half of women who received the vaccine in a clinical trial. The goal, say the scientists, was to find nonsurgical ways to treat precancerous lesions caused by HPV.
› Verified 4 days ago
Kara Magee Maxsimic, NP Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 163 Belleville Ave, Belleville, NJ 07109 Phone: 973-302-4644 | |
Shine A Kannampilly, RNFA Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1a Beverly Ct, Belleville, NJ 07109 Phone: 973-759-2969 | |
Kristi Baron, C.R.N.A. Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 1 Clara Maass Dr, Belleville, NJ 07109 Phone: 973-450-2000 | |
Eileen M Hassa, DNP Registered Nurse Medicare: Medicare Enrolled Practice Location: 1 Clara Maass Dr, Belleville, NJ 07109 Phone: 973-450-2000 | |
Mrs. Maria Luisa Colon-bloschock, RNFA Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 7 Academy St, Belleville, NJ 07109 Phone: 973-751-2853 | |
Dania Jean-louis, APN Registered Nurse Medicare: Medicare Enrolled Practice Location: 1 Clara Maass Dr, Belleville, NJ 07109 Phone: 973-450-2000 |